Roar BidCo has received competition clearance from the EU Commission for the recommended offer to the shareholders in Recipharm AB (publ) and Holders of Convertible Bonds
On 14 December 2020, EQT IX[1] ("EQT IX"), through Roar BidCo AB[2] ("Roar BidCo"), announced a public offer to the shareholders and holders of the Senior Unsecured Convertible Bonds (the "Convertible Bonds") ("Holders of Convertible Bonds") in Recipharm AB (publ) ("Recipharm" or the "Company") to tender all their shares[3] and Convertible Bonds to Roar BidCo (the "Offer"). The Offer was subsequently increased on 28 January 2021 (the "Revised Offer"). Roar BidCo has received the necessary competition clearances from the EU Commission for the recommended Revised Offer. This means that